SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 138 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,461 | +7.8% | 357,343 | +40.9% | 0.02% | +12.5% |
Q1 2024 | $12,487 | +34.8% | 253,703 | -0.0% | 0.02% | +23.1% |
Q4 2023 | $9,262 | +60.4% | 253,741 | +1.6% | 0.01% | +62.5% |
Q3 2023 | $5,774 | -11.7% | 249,754 | +0.1% | 0.01% | 0.0% |
Q2 2023 | $6,540 | +38.4% | 249,418 | +35.9% | 0.01% | +33.3% |
Q1 2023 | $4,724 | -4.3% | 183,546 | -3.3% | 0.01% | -14.3% |
Q4 2022 | $4,935 | -99.9% | 189,734 | -9.1% | 0.01% | -22.2% |
Q3 2022 | $5,952,000 | +27.5% | 208,635 | +10.0% | 0.01% | +50.0% |
Q2 2022 | $4,669,000 | -55.4% | 189,650 | +2.1% | 0.01% | -45.5% |
Q1 2022 | $10,480,000 | -8.9% | 185,678 | -0.0% | 0.01% | -8.3% |
Q4 2021 | $11,509,000 | +78.5% | 185,681 | +82.7% | 0.01% | +71.4% |
Q3 2021 | $6,447,000 | +209.4% | 101,629 | +301.9% | 0.01% | +250.0% |
Q2 2021 | $2,084,000 | +26.5% | 25,288 | +12.9% | 0.00% | 0.0% |
Q1 2021 | $1,648,000 | +8.7% | 22,400 | +7.2% | 0.00% | 0.0% |
Q4 2020 | $1,516,000 | +63.0% | 20,900 | +7.2% | 0.00% | +100.0% |
Q3 2020 | $930,000 | +13.6% | 19,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $819,000 | +222.4% | 19,500 | +107.4% | 0.00% | – |
Q1 2020 | $254,000 | -29.8% | 9,400 | 0.0% | 0.00% | – |
Q4 2019 | $362,000 | – | 9,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |